Publicacions en col·laboració amb investigadors/es de Hospital Universitari de Girona Dr. Josep Trueta (8)

2007

  1. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: The modulator role of PI3K/Akt

    Neoplasia

  2. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells

    Oncology Reports, Vol. 18, Núm. 4, pp. 973-980

2006

  1. HER2 (erb B-2)-targeted effects of the ω-3 polyunsaturated. Fatty acid α-linolenic acid (ALA; 18:3n-3) in breast cancer cells: The 〈fat features〉 of the 〈Mediterranean diet〉 as an 〈anti-HER2 cocktail〉

    Clinical and Translational Oncology, Vol. 8, Núm. 11, pp. 812-820

2004

  1. Dietary fatty acids regulate the activation status of Her-2/neu (c-erb B-2) oncogene in breast cancer cells [1]

    Annals of Oncology

  2. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Núm. 29, pp. 10715-10720

  3. Initially Metastatic Breast Carcinoma Has a Distinct Disease Pattern but an Equivalent Outcome Compared with Recurrent Metastatic Breast Carcinoma

    Cancer, Vol. 100, Núm. 9, pp. 1833-1842

  4. Trastuzumab plus tamoxifen: Anti-proliferative and molecular interactions in breast carcinoma

    Breast Cancer Research and Treatment, Vol. 86, Núm. 2, pp. 125-137

  5. ω-6 polyunsaturated fatty acid γ-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression

    Oncology Reports, Vol. 11, Núm. 6, pp. 1241-1252